Four UK centres will conduct the \u2018Stratification of Clinically Vulnerable People for COVID-19 Risk using Antibody Testing (STRAVINSKY)\u2019 study over the next two years, to identify the patient groups most vulnerable to COVID-19.
The Pandemic Sciences Institute and the UK's Defence Science and Technology Laboratory (Dstl) have agreed to jointly study the dangerous pathogens that could cause future pandemics.
Academic representatives from Benem\u00e9rita Universidad Aut\u00f3noma de Puebla (BUAP), one of the leading universities in Mexico, paid a visit to NDM\u2019s Jenner Institute.
The Dr Stanley Ho Medical Development Foundation will continue its funding support for The Centre for Personalised Medicine (CPM) for further seven years.
Researchers at NDM\u2019s Wellcome Centre for Human Genetics and Nuffield Department of Women\u2019s & Reproductive Health, in collaboration with 25 teams across the world have found compelling genetic evidence linking endometriosis to other types of pain.
Rare diseases are a global health challenge. To address this, organisations around the world, including the Nuffield Department of Medicine (NDM), are working together to find solutions for patients.
A team from Mahidol Oxford Tropical Medicine Research Unit (MORU) in Bangkok along with Prof Varghese and the INTREST trial investigators in India, finds the combination of antibiotics is significantly more effective than the current monotherapy.
Researchers at NDM's Mahidol Oxford Tropical Medicine Research Unit found that high doses of the drug ivermectin, controversially recommended by some high-profile political and media figures during the COVID-19 pandemic, are ineffective at treating the COVID-19 virus.
A team of experts at NDM\u2019s Pandemic Sciences Institute and the Department of Statistics at the University of Warwick estimate the NHS COVID-19 app prevented around 1 million cases, 44,000 hospitalisations and 9,600 deaths during its first year.
The Coronavirus Vaccines Research and Development Roadmap is a comprehensive plan to galvanize a global effort to protect the world from this large and dangerous family of viruses.
The Lithuanian Ambassador to the United Kingdom, His Excellency Mr Eitvydas Bajar\u016bnas, paid a visit to Professor Skirmantas Kriau\u010dionis of the Ludwig Institute for Cancer Research at the Nuffield Department of Medicine.
Researchers from NDM\u2019s Target Discovery Institute and CAMS Oxford Institute, and the Department of Biochemistry uncovered at the molecular level how protein BIRC6 (a giant ubiquitin ligase) keeps cells alive.
DART (Dengue Advanced Readiness Tools), is a new project supported by Wellcome to use climate data to better predict and prepare for infectious diseases outbreaks.
The Mahidol Oxford Tropical Medicine Research Unit (MORU) has begun a Phase II trial to demonstrate that R21/matrix M is well-tolerated and immunogenic when administered with the antimalarial drug combination.
Researchers from Wellcome Centre for Human Genetics at the Nuffield Department of Medicine, have discovered that a rare type of genetic variant can be responsible for two well-known skeletal disorders.
DPhil student at the Jenner Institute, Romain Guyon is among the researchers who received the 2022 Michelson Prizes: Next Generation Grants, announced by Michelson Medical Research Foundation and Human Immunome Project.
Since the start of the pandemic, the CAMS-Oxford Institute (COI) has carried out 11 projects to better understand COVID-19, resulting in 21 published research articles.
A new Memorandum of Understanding (MoU) to facilitate collaboration in the field of pandemic preparedness and to promote further cooperation between the University of Oxford and Diamond Light Source, the UK\u2019s national synchrotron has been agreed upon.
![\"\"](\"https://www.ndm.ox.ac.uk/news/landmark-antibody-study-to-test-immune-responses-against-covid-19/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n